CLINICAL_TRIALS
trial_result
· 2023-02-09
Clinical Trial Update: Study to Evaluate the Efficacy and Safety of ORMD-0801 in Subjects With Type 2 Diabetes Mellitus [Phase 3]
Summary
A Phase 3 clinical trial evaluating the efficacy and safety of ORMD-0801 in subjects with Type 2 Diabetes Mellitus was terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Oramed, Ltd. | Conditions: Type 2 Diabetes Mellitus | Phase 3 | Status: TERMINATED